Insulin resistance is concomitant with type 2 diabetes, obesity, hypertension, and other features of the metabolic syndrome. Because insulin resistance is associated with cardiovascular disease, both ...

Formally started in 1971 with the discovery of the insulin receptor, the field of insulin signalling has by now resolved many questions related to the cellular, biochemical foundation of the hormone's ...

The term 'insulin resistance' refers to a decrease in a target cell's metabolic response to insulin, or, at the whole-organism level, an impaired lowering effect of circulating or injected insulin on ...

Insulin resistance precedes and predicts the onset of type 2 diabetes mellitus (DM2), a chronic disease that causes high morbidity and mortality worldwide. In affected people, insulin is unable to ...

A clinical trial found that metformin, a drug typically used for type 2 diabetes, reduced insulin requirements by around 12% ...

The findings have important implications, the authors wrote, as the study confirms “the potential clinical utility of empagliflozin for the treatment of obesity and related metabolic disorders, such ...

MENLO PARK, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (“CohBar” or the “Company”), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to ...

A cheap, century-old medication can improve life for people with type 1 diabetes, according to new research. A clinical trial ...

By Dr. Priyom Bose, Ph.D. A 26-week trial reveals that metformin, long viewed as a promising add-on therapy, lowers insulin ...

Nature study shows a new polymer can deliver insulin through the skin, raising hopes for a painless, needle-free diabetes treatment that performs as effectively as injections ...

The surprising findings could improve how doctors manage type 1 diabetes and ease the significant burden that people with the condition face when using insulin alone. In their published paper in ...

We are delighted to present our Week 52 long-term follow up data at WCIRDC, a meeting renowned for showcasing exciting advances in diabetes and metabolic research,” said Mick Hitchcock, Ph.D., Interim ...